Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Chimerix, Inc.
  6. News
  7. Summary
    CMRX   US16934W1062

CHIMERIX, INC.

(CMRX)
  Report
Real-time Estimate Cboe BZX  -  01:34 2022-09-29 pm EDT
1.875 USD   -2.85%
09/28Chimerix : UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K
PU
09/28Chimerix Inc : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (form 8-K)
AQ
09/27Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA, the First FDA-Approved Smallpox Oral Antiviral for All Ages
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about CHIMERIX, INC.
09/28Chimerix : UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K
PU
09/26Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions
AQ
09/26Emergent BioSolutions Inc. completed the acquisition of Exclusive Worldwide Rights to B..
CI
09/07Capital One Starts Chimerix at Overweight With $7 Price Target
MT
09/06Chimerix to Present at H.C. Wainwright 24th Annual Global Investment Conference
AQ
08/29Chimerix Chief Business Officer Michael Andriole Executes Purchase of 50,000 Shares
MT
08/29Sector Update: Health Care Stocks Moderately Lower in Late Trade
MT
08/29Sector Update: Health Care
MT
08/29Chimerix Gets Up to $680 Million US Government Contract for Tembexa Smallpox Treatment;..
MT
08/29Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox
AQ
08/29Chimerix Wins BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox
CI
08/29Chimerix Shares Jump After Smallpox Drug Supply Deal
DJ
08/09Wedbush Cuts Price Target on Chimerix to $6 From $8, Citing ONC201 Estimated Launch, Ke..
MT
08/08Chimerix : Reports Second Quarter 2022 Financial Results and Provides Operational Update -..
PU
08/08Transcript : Chimerix, Inc., Q2 2022 Earnings Call, Aug 08, 2022
CI
More most relevant news
All news about CHIMERIX, INC.
09/28Chimerix : UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K
PU
09/28Chimerix Inc : Entry into a Material Definitive Agreement, Completion of Acquisition or Di..
AQ
09/27Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA, t..
AQ
09/26Emergent BioSolutions Completes Acquisition of Rights to Smallpox Oral Antiviral Tembex..
MT
09/26Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions
AQ
09/26Emergent BioSolutions Inc. completed the acquisition of Exclusive Worldwide Rights to B..
CI
09/07Capital One Starts Chimerix at Overweight With $7 Price Target
MT
09/06Chimerix to Present at H.C. Wainwright 24th Annual Global Investment Conference
AQ
08/31Chimerix Inc : Entry into a Material Definitive Agreement (form 8-K)
AQ
08/31Testing, Treatment, and Vaccines are the Three Ways Companies Can Fight Monkeypox (SKHH..
AQ
More news
News in other languages on CHIMERIX, INC.
09/26Emergent BioSolutions Inc. (NYSE:EBS) a finalisé l'acqu..
08/29Le directeur commercial de Chimerix, Michael Andriole, exécute l'achat de 50 000 action..
08/29Mise à jour sectorielle : Les actions du secteur de la santé en ..
08/29Mise à jour sectorielle : Soins de santé
08/29Chimerix obtient un contrat du gouvernement américain pouvant atteindre 680 millions de..
08/29Chimerix remporte un contrat BARDA pour TEMBEXA comme contre-mesure médicale contre la ..
08/08Earnings Flash (CMRX) CHIMERIX affiche un revenu de 440 000 $ pour le T2
08/08Chimerix, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le ..
07/25Les actions de SIGA Technologies et de Chimerix s'envolent après que l'OMS a qualifié l..
06/28Chimerix, Inc. conclut un accord d'approvisionnement avec une tierce partie en dehors d..
More news
Analyst Recommendations on CHIMERIX, INC.
09/07Capital One Starts Chimerix at Overweight With $7 Price Target
MT
08/09Wedbush Cuts Price Target on Chimerix to $6 From $8, Citing ONC201 Estimated Launch, Ke..
MT
05/17HC Wainwright Adjusts Price Target on Chimerix to $11 From $24, Reiterates Buy Rating
MT
05/16Cowen Lowers Price Target for Chimerix to $10 From $18, Maintains Outperform Rating
MT
05/16Wedbush Adjusts Chimerix Price Target to $8 From $14, Maintains Outperform Rating
MT
More recommendations
Press releases
09/28Chimerix : UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K
PU
09/28Chimerix Inc : Entry into a Material Definitive Agreement, Completion of Acquisition or Di..
AQ
09/27Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA, t..
AQ
09/26Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions
AQ
09/06Chimerix to Present at H.C. Wainwright 24th Annual Global Investment Conference
AQ
More press releases
Upcoming event on CHIMERIX, INC.